The post Best TipRanks Alternatives in February 2026 by Ryan Peterson appeared first on Benzinga . Visit Benzinga to get more great content like this. Looking to up your stock game without using TipRanks? We’ve got you covered. Whether you’re in need of a r obust stock screener , a detailed dividend calendar or insights from the best stock analysts, there’s a perfect alternative out there for you,...
The post Best TipRanks Alternatives in February 2026 by Ryan Peterson appeared first on Benzinga . Visit Benzinga to get more great content like this. Looking to up your stock game without using TipRanks? We’ve got you covered. Whether you’re in need of a r obust stock screener , a detailed dividend calendar or insights from the best stock analysts, there’s a perfect alternative out there for you, such as Benzinga Pro , TradingView and Interactive Brokers . Dive into our top picks for the best TipRanks alternatives to supercharge your investing strategy. Quick Look at the Top TipRanks Alternatives: Best for real-time data : BenzingaPro Best for social trading : TradingView Best for comprehensive tools : Interactive Brokers Best for in-depth research : Stock Rover Best for analyst ratings : Zacks Best for visual financial analysis : Simply Wall St Best for commission-free trading : Moomoo Best for investment ideas : Seeking Alpha Table of contents [ Show ] Quick Look at the Top TipRanks Alternatives: 8 Best Alternatives to TipRanks 1. Best for Real-Time Data: BenzingaPro 2. Best for Social Trading: TradingView 3. Best for Comprehensive Tools: Interactive Brokers 4. Best for In-Depth Research: Stock Rover 5. Best for Analyst Ratings: Zacks 6. Best for Visual Financial Analysis: Simply Wall St 7. Best for Commission-Free Trading: Moomoo 8. Best for Investment Ideas: Seeking Alpha What Is TipRanks? Why TipRanks Might Not Be Right for You Choosing the Best TipRanks Alternative Frequently Asked Questions 8 Best Alternatives to TipRanks What platforms are better than TipRanks? Let’s break it down: 1. Best for Real-Time Data: BenzingaPro Best For All Trading Levels Overall Rating get started BenzingaPro offers a robust market analysis platform with real-time news, actionable alerts and detailed stock profiles. It’s designed for traders needing up-to-the-minute information to quickly make informed decisions. Fees: Plans start at $37/month (Basic), with higher tiers like “Str...
In this article EL-FR IHG-GB ANTO-GB RIO-GB BHP-AU Follow your favorite stocks CREATE FREE ACCOUNT The City of London skyline at sunset. Gary Yeowell | Digitalvision | Getty Images LONDON — European stocks are expected to open lower on Tuesday as investors keep an eye on earnings. The U.K.'s FTSE index is seen opening 0.2% lower, and Germany's DAX , France's CAC 40 and Italy's FTSE MIB are all see...
In this article EL-FR IHG-GB ANTO-GB RIO-GB BHP-AU Follow your favorite stocks CREATE FREE ACCOUNT The City of London skyline at sunset. Gary Yeowell | Digitalvision | Getty Images LONDON — European stocks are expected to open lower on Tuesday as investors keep an eye on earnings. The U.K.'s FTSE index is seen opening 0.2% lower, and Germany's DAX , France's CAC 40 and Italy's FTSE MIB are all seen down 0.4%, according to data from IG. Regional markets edged higher on Monday, as investors digested comments from this year's Munich Security Conference. Earnings remain in focus for investors, with miners Antofagasta and BHP Group due to report Tuesday, as well as InterContinental Hotels Group and EssilorLuxottica . Data releases include German inflation and economic sentiment and U.K. unemployment figures. Overnight, S&P 500 futures were near flat following two straight negative weeks for the benchmark; U.S markets were shut on Monday for Presidents' Day. Asian financial markets were treading carefully on Tuesday in holiday-thinned trading, with mainland Chinese, Hong Kong, Singapore, Taiwan and South Korea markets closed on Tuesday for Lunar New Year holidays.
Daniel Grizelj/DigitalVision via Getty Images I previously covered Nebius Group ( NBIS ) in November 2025, discussing why I had finally upgraded the stock to a Buy then, thanks to the improved margin of safety/cheaper valuation arising from the prior meltdown, the growing cloud backlog, and the robust robotaxi monetization opportunity from the end of FY2025 onwards. In this article, I shall discus...
Daniel Grizelj/DigitalVision via Getty Images I previously covered Nebius Group ( NBIS ) in November 2025, discussing why I had finally upgraded the stock to a Buy then, thanks to the improved margin of safety/cheaper valuation arising from the prior meltdown, the growing cloud backlog, and the robust robotaxi monetization opportunity from the end of FY2025 onwards. In this article, I shall discuss why I am reiterating my Buy rating for the NBIS stock, thanks to the improved risk/reward profile from the ongoing consolidation along the 50/100/200-day moving averages and the stock's established Q4'25 support levels of $73s. This is on top of the high-growth cloud prospects as observed in the management's aggressive capacity expansion and the promising FY2026 guidance, despite the risks arising from the elevated short interest and the likely to be delayed EPS profitability. NBIS Proves Its AI Beneficiary Status NBIS 1Y Stock Price ( TradingView ) Since my last Buy rating, NBIS has mostly traded sideways between the established Q4'25 support levels of $73s and the Q4'25 resistance levels of $105s, with a similar development also observed in its hyperscaler/neocloud peers in varying degrees. This is despite the undeniable durability of the AI/cloud-related spending trends as reiterated by numerous market leaders during the Q4'25 earnings season, with it highlighting the cooling market sentiments worsened by the prior market rotation to value/dividend-oriented sectors since December 2025. This is despite NBIS' accelerated core AI cloud revenues growth to $214.2M in FQ4'25 (+800% YoY), with the segment comprising "94% of their total group revenues." The insatiable compute demand profile has also contributed to their core AI cloud's peak utilization and sold-out capacity in FQ4'25, with the strong pricing trends already triggering their accelerated capacity expansion plans and the contracted power increase guidance to over 3 GWs in 2026 . This is compared to the current pro...
Zorica Nastasic/E+ via Getty Images AbbVie ( ABBV ), a leader in the JAK and IL-23 inhibitor markets, released strong Q4 numbers, but its stock price fell 5.1% that day. And first, I will note the dry numbers. So, its revenue rose 10.1% year-over-year to $16.6 billion and beat my 'base case' scenario by $180 million, mainly due to the stronger demand for Skyrizi, Qulipta, and Elahere. And its non-...
Zorica Nastasic/E+ via Getty Images AbbVie ( ABBV ), a leader in the JAK and IL-23 inhibitor markets, released strong Q4 numbers, but its stock price fell 5.1% that day. And first, I will note the dry numbers. So, its revenue rose 10.1% year-over-year to $16.6 billion and beat my 'base case' scenario by $180 million, mainly due to the stronger demand for Skyrizi, Qulipta, and Elahere. And its non-GAAP EPS also topped the consensus estimate, as in the past 4 quarters, but this time by 6 cents . Source: graph was made by Author But before I get into the details of AbbVie's drugs, whose performance remains strong, and the "dark spots" in its Eye Care portfolio, I want to point out two milestones, partly due to which I continue to cover it with a 'Buy' rating. I'll start with AbbVie's $5.6 billion agreement with RemeGen, which was announced on January 12 . According to it, AbbVie acquired the rights to develop and commercialize RC148, a PD-1/VEGF-targeted bispecific antibody for the treatment of multiple advanced solid tumors. And yes, AbbVie didn't discuss the clinical data for RC148 in its press release. So, I looked at RemeGen's presentations. I'll take a Phase 1/2 clinical trial [ NCT06016062 ] as an example. In it, patients with non-small cell lung cancer [ la/NSCLC ] who received RC148 [20 mg/kg] plus docetaxel, an anti-mitotic chemotherapy agent, showed a cORR of an impressive 66.7%, compared to only 28.6% in the RC148 [10 mg/kg]-docetaxel arm. That is, at the current moment, I can make an interim conclusion that RC148 has the potential to become an 'SoC' in the treatment of this type of cancer. Source: RemeGen And beyond RemeGen/AbbVie's product candidate, I also want to talk about the results of the Phase 3 ECLIPSE trial [ NCT06241313 ] that assessed the efficacy of Qulipta [ 60 mg atogepant ] in treating people living with migraine. So, 24.3% of participants taking AbbVie's CGRP receptor antagonist achieved pain freedom at two hours post-dose, which is almost ...
The first of a three-part series about the former prime minister’s path to power. Plus, the Fukushima catastrophe 15 years on. Here’s what to watch this evening 9pm, Channel 4 “Never lose your temper. Except on purpose.” Tony Blair’s advice on negotiation to his chief of staff Jonathan Powell is a neat insight into the man in general. This three-part deep dive shows Blair as a calculating communic...
The first of a three-part series about the former prime minister’s path to power. Plus, the Fukushima catastrophe 15 years on. Here’s what to watch this evening 9pm, Channel 4 “Never lose your temper. Except on purpose.” Tony Blair’s advice on negotiation to his chief of staff Jonathan Powell is a neat insight into the man in general. This three-part deep dive shows Blair as a calculating communicator, but an insubstantial political thinker whose greatest achievements were founded upon being all things to all people. What fuelled his insistent will to power? From his constituency of Sedgefield to the horror of Iraq, this singular political journey is tracked but never quite explained. Phil Harrison Continue reading...
IT之家2 月 17 日消息 ，当地时间周日，一次性买断 FSD 的选项已从美国官网的在线配置器中正式下架，特斯拉 FSD 功能套件正式转向仅订阅制。 不过，仍有一种方式可以一次性买断 FSD 功能，无需车主每月为这套驾驶辅助系统付费，但前提是购买 Model S 或 Model X。 数月前，特斯拉为 Model S 和 Model X 推出了专属的“豪华套装（Luxe Package）”，其中...
IT之家2 月 17 日消息 ，当地时间周日，一次性买断 FSD 的选项已从美国官网的在线配置器中正式下架，特斯拉 FSD 功能套件正式转向仅订阅制。 不过，仍有一种方式可以一次性买断 FSD 功能，无需车主每月为这套驾驶辅助系统付费，但前提是购买 Model S 或 Model X。 数月前，特斯拉为 Model S 和 Model X 推出了专属的“豪华套装（Luxe Package）”，其中包含： ·车辆终身 FSD 功能 ·全球超 75,000 个超级充电站的终身免费超充 ·终身高级车载连接服务 ·四年高端服务套餐，包含轮毂 轮胎 保护、挡风玻璃保护及定期保养服务 此外，购买 Cyberbeast—— 即 Cybertruck 的顶配版本，也可享受这一待遇。 这个小漏洞能让车主避开月费，但相关细则已出现调整：特斯拉新增条款规定，上述权益不可转让给后续车主或其他车辆。该限制适用于豪华套装中附带的 FSD 与超级充电权益。 目前，美国市场特斯拉 FSD 订阅费仍为每月 99 美元（IT之家 注： 现汇率约合 684.3 元人民币），但随着功能升级，未来价格预计会上调。按照马斯克对 Cybercab 项目的预估，特斯拉的无监督 FSD 功能已近成熟。未来特斯拉有可能推出无监督版与有监督版 FSD，实行不同定价，但该消息尚未得到证实。 在其他国家，特斯拉已推迟 FSD 一次性购买的截止日期，例如澳大利亚已调整至 3 月 31 日。
Hong Kong will welcome the Year of the Horse with a 23-minute Lunar New Year fireworks display on Wednesday, showcasing vibrant elements inspired by the energy and spirit of horses. Themed “Prosperity Gallops Across Hong Kong,” the fireworks show is solely sponsored by the Hong Kong Jockey Club at a cost of HK$19 million (US$2.4 million). The South China Morning Post takes a closer look at the hig...
Hong Kong will welcome the Year of the Horse with a 23-minute Lunar New Year fireworks display on Wednesday, showcasing vibrant elements inspired by the energy and spirit of horses. Themed “Prosperity Gallops Across Hong Kong,” the fireworks show is solely sponsored by the Hong Kong Jockey Club at a cost of HK$19 million (US$2.4 million). The South China Morning Post takes a closer look at the highlights of the extravaganza and the best spots to watch it from. 1. What are the highlights of the...
In the run-up to Lunar New Year, Chinese consumers were busy choosing gold jewellery, a traditional gift with deep cultural connotations, as strong market sentiment overshadowed sharp fluctuations in gold prices and assessments of the sector’s outlook by investment banks remained upbeat. Jewellers offered small discounts to boost holiday sales. For example, Chow Tai Fook Jewellery Group, China’s l...
In the run-up to Lunar New Year, Chinese consumers were busy choosing gold jewellery, a traditional gift with deep cultural connotations, as strong market sentiment overshadowed sharp fluctuations in gold prices and assessments of the sector’s outlook by investment banks remained upbeat. Jewellers offered small discounts to boost holiday sales. For example, Chow Tai Fook Jewellery Group, China’s largest retailer by store count, launched an 80 yuan (US$12) discount per gram on gold items in its...